European Healthtech startup funding raised during Q4 2022.
In Q4 2022, 174 European Healthtech companies raised a combined €2.0B across 182 funding rounds, down 32.5% versus Q4 2021. UK led by capital raised, and EIC Accelerator was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Vectivbio | Other | Oct 2022 | €127M |
| TauRx Pharmaceuticals | Other | Nov 2022 | €115M |
| Demant AS | Debt | Nov 2022 | €115M |
| Osler Diagnostics | Series C |
17 exits · €2.9B disclosed.
| Immucor | Acquisition | Nov 2022 | €2.0B |
| Neogene Therapeutics | Acquisition | Nov 2022 | €310M |
| Cordis | Acquisition | Oct 2022 | €240M |
| Focus-X Therapeutics | Acquisition | Nov 2022 | €237M |
| Oculis | IPO | Oct 2022 | €82M |
| BModesto | Acquisition | Nov 2022 | €75M |
| Nov 2022 |
| €85M |
| Resolve Biosciences | Series B | Oct 2022 | €72M |
| CatalYm | Series C | Nov 2022 | €50M |
| MinervaX | Debt | Dec 2022 | €50M |
| Univercells | Other | Oct 2022 | €44M |
| Numares | Other | Dec 2022 | €40M |
| Novadip Biosciences | Series B | Nov 2022 | €40M |
| Nucleome Therapeutics | Series A | Oct 2022 | €38M |
| Opna Bio | Series A | Nov 2022 | €37M |
| anokion | Other | Oct 2022 | €36M |
| Mablink Bioscience | Series A | Oct 2022 | €31M |
| Aqemia | Series A | Oct 2022 | €30M |
